ScholarIQanswers from OpenAlex & ORCID
Gerald W. Prager
ResearcherPublications, citations & collaboration network
Gerald W. Prager is a researcher indexed in ScholarIQ from OpenAlex & ORCID.
How many works does Gerald W. Prager have?
ScholarIQindexed works
Gerald W. Prager has 390 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does Gerald W. Prager have?
ScholarIQcitation count
Gerald W. Prager has 6,751 citations in the OpenAlex counts ScholarIQ stores.
What is the h-index of Gerald W. Prager?
ScholarIQh-index
Gerald W. Prager has an h-index of 44 in OpenAlex.
What is the i10-index of Gerald W. Prager?
ScholarIQi10-index
Gerald W. Prager has an i10-index of 97 in OpenAlex.
What is the ORCID of Gerald W. Prager?
ScholarIQorcid
The ORCID for Gerald W. Prager is on the source record.
What is the OpenAlex record for Gerald W. Prager?
ScholarIQopenalex
The OpenAlex for Gerald W. Prager is on the source record.
What are the most-cited papers on Gerald W. Prager?
ScholarIQmost cited works
Pancreatic cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up
Thierry Conroy, Per Pfeiffer, Valérie Vilgrain, Ángela Lamarca, Thomas Seufferlein, Eileen M. O’Reilly, Thilo Hackert, Talia Golan, Gerald W. Prager, Karin Haustermans, Arndt Vogel, Michel Ducreux
Dabrafenib plus trametinib in patients with BRAFV600E-mutated biliary tract cancer (ROAR): a phase 2, open-label, single-arm, multicentre basket trial
Vivek Subbiah, Ulrik Lassen, Elena Élez, Antoîne Italiano, Giuseppe Curigliano, Milind Javle, Filippo de Braud, Gerald W. Prager, Richard Greil, Alexander Stein, Angelica Fasolo, Jan H.M. Schellens, Patrick Y. Wen, Kert Viele, Aislyn Boran, Eduard Gasal, Paul Burgess, Palanichamy Ilankumaran, Zev A. Wainberg
Trifluridine–Tipiracil and Bevacizumab in Refractory Metastatic Colorectal Cancer
Gerald W. Prager, Julien Taı̈eb, Marwan Fakih, Fortunato Ciardiello, Eric Van Cutsem, Elena Élez, Felipe Melo Cruz, Lucjan Wyrwicz, Daniil Stroyakovskiy, Zsuzsanna Pápai, Pierre-Guillaume Poureau, Gábor Liposits, Chiara Cremolini, Igor Bondarenko, Dominik Paul Modest, Karim A. Benhadji, Nadia Amellal, Catherine Leger, Loïck Vidot, Josep Tabernero
uPAR – uPA – PAI-1 interactions and signaling: A vascular biologist’s view
Judit Mihaly, Gerald W. Prager, Bernd R. Binder
Plasminogen Activator Inhibitor 1: Physiological and Pathophysiological Roles
Bernd R. Binder, Günter Christ, Флориан Грубер, Nelly Grubic, Peter Hufnagl, Michael Krebs, Judit Mihaly, Gerald W. Prager